Fundraising Fox

Merifin Capital

Venture capital

Brussels · Seed–Late Stage · 5 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Merifin Capital pursues above-average returns by backing businesses with focused management teams and attractive growth prospects. It operates across early and late stage venture capital, buy-outs, and turn-around situations globally, and offers portfolio companies access to its international network of partners and contacts. The firm typically makes equity investments and adopts a long-term investment horizon, agreeing on a realization strategy with the companies it backs.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Late Stage
Check
$216K – $3.2M
HQ
Brussels, BE
Instruments
Equity
Founded
1985
Tracked investments
1

Team · 5 people

from curated & public directories

What they invest in

from 1 of 1 portfolio companies

Biotech ×1Healthtech ×1

Investments · 1 tracked

founders shown can be your intro path
F2Gf2g.com

F2G is a biotechnology company developing novel antifungal therapies to treat rare, life-threatening fungal infections in defined patient populations.

BiotechHealthtech

Co-investorsAdvent Life SciencesAisling CapitalAMR Action FundAstellas Venture Management LLCBrace PharmaSofinnova Partners+3 more

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does Merifin Capital invest at?
Merifin Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is Merifin Capital's typical check size?
Merifin Capital typically writes checks of $216K – $3.2M.
What sectors does Merifin Capital focus on?
Merifin Capital focuses on Sector Agnostic.
Where is Merifin Capital located?
Merifin Capital is headquartered in Brussels, BE.

Similar investors

Featured in lists